SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
NCT05300269
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced Rectal Cancer
Interventions
DRUG:
SHR-1701；Capecitabine；Oxaliplatin
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.